TRPV1 mediates inflammation and hyperplasia in imiquimod (IMQ)-induced psoriasiform dermatitis (PsD) in mice

Journal of Dermatological Science

Volumn 92, Issue 3, 2018, Pages 264-271

  Zhou, Yan ^a,b   Follansbee, Taylor ^c   Wu, Xuesong ^a   Han, Dan ^a,b   Yu, Sebastian ^a   Domocos, Dan T ^c   Shi, Zhenrui ^a   Carstens, Mirela ^c   Carstens, Earl ^c   Hwang, Samuel T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Itch; Pain neuroinflammation; Psoriasis

Indexed keywords

CALGRANULIN A; CD3 ANTIGEN; IMIQUIMOD; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASE C; VANILLOID RECEPTOR 1; CYTOKINE; TRPV1 PROTEIN, MOUSE; VANILLOID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HYPERPLASIA; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; SKIN HYPERPLASIA; SKIN WATER LOSS; ANIMAL; C57BL MOUSE; DISEASE MODEL; EPIDERMIS; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; THERMOREGULATION;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; EPIDERMIS; FEMALE; HUMANS; HYPERPLASIA; IMIQUIMOD; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PSORIASIS; TRPV CATION CHANNELS; WATER LOSS, INSENSIBLE;

EID: 85057794944     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2018.11.009     Document Type: Article

References (25)

1. Chiricozzi, A., Romanelli, P., Volpe, E., Borsellino, G., Romanelli, M., Scanning the immunopathogenesis of psoriasis. Int. J. Mol. Sci., 19(1), 2018.
2. Saggini, A., Chimenti, S., Chiricozzi, A., IL-6 as a druggable target in psoriasis: focus on pustular variants. J. Immunol. Res., 2014, 2014, 964069.
3. Giang, J., Seelen, M.A.J., van Doorn, M.B.A., Rissmann, R., Prens, E.P., Damman, J., Complement activation in inflammatory skin diseases. Front. Immunol., 9, 2018, 639.
4. Hunter, H.J., Griffiths, C.E., Kleyn, C.E., Does psychosocial stress play a role in the exacerbation of psoriasis?. Br. J. Dermatol. 169:5 (2013), 965–974.
5. Arck, P.C., Slominski, A., Theoharides, T.C., Peters, E.M., Paus, R., Neuroimmunology of stress: skin takes center stage. J. Invest. Dermatol. 126:8 (2006), 1697–1704.
6. Choi, J.E., Di Nardo, A., Skin neurogenic inflammation. Semin. Immunopathol. 40:3 (2018), 249–259.
7. Riol-Blanco, L., Ordovas-Montanes, J., Perro, M., Naval, E., Thiriot, A., Alvarez, D., Paust, S., Wood, J.N., von Andrian, U.H., Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation. Nature 510:7503 (2014), 157–161.
8. Cevikbas, F., Wang, X., Akiyama, T., Kempkes, C., Savinko, T., Antal, A., Kukova, G., Buhl, T., Ikoma, A., Buddenkotte, J., Soumelis, V., Feld, M., Alenius, H., Dillon, S.R., Carstens, E., Homey, B., Basbaum, A., Steinhoff, M., A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: involvement of TRPV1 and TRPA1. J. Allergy Clin. Immunol. 133:2 (2014), 448–460.
9. Bonchak, J.G., Swerlick, R.A., Emerging therapies for atopic dermatitis: TRPV1 antagonists. J. Am. Acad. Dermatol. 78:3S1 (2018), S63–S66.
10. Huang, W.X., Yu, F., Sanchez, R.M., Liu, Y.Q., Min, J.W., Hu, J.J., Bsoul, N.B., Han, S., Yin, J., Liu, W.H., He, X.H., Peng, B.W., TRPV1 promotes repetitive febrile seizures by pro-inflammatory cytokines in immature brain. Brain Behav. Immun. 48 (2015), 68–77.
11. Gouin, O., L'Herondelle, K., Lebonvallet, N., Le Gall-Ianotto, C., Sakka, M., Buhe, V., Plee-Gautier, E., Carre, J.L., Lefeuvre, L., Misery, L., Le Garrec, R., TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization. Protein Cell 8:9 (2017), 644–661.
12. Roblin, D., Yosipovitch, G., Boyce, B., Robinson, J., Sandy, J., Mainero, V., Wickramasinghe, R., Anand, U., Anand, P., Topical TrkA kinase inhibitor CT327 is an effective, novel therapy for the treatment of pruritus due to psoriasis: results from experimental studies, and efficacy and safety of CT327 in a phase 2b clinical trial in patients with psoriasis. Acta Derm. Venereol. 95:5 (2015), 542–548.
13. Nattkemper, L.A., Tey, H.L., Valdes-Rodriguez, R., Lee, H., Mollanazar, N.K., Albornoz, C., Sanders, K.M., Yosipovitch, G., The genetics of chronic itch: gene expression in the skin of patients with atopic dermatitis and psoriasis with severe itch. J. Invest. Dermatol. 138:6 (2018), 1311–1317.
14. Pecze, L., Pelsoczi, P., Kecskes, M., Winter, Z., Papp, A., Kaszas, K., Letoha, T., Vizler, C., Olah, Z., Resiniferatoxin mediated ablation of TRPV1+ neurons removes TRPA1 as well. Can. J. Neurol. Sci. 36:2 (2009), 234–241.
15. Mohammed, D., Matts, P.J., Hadgraft, J., Lane, M.E., Depth profiling of stratum corneum biophysical and molecular properties. Br. J. Dermatol. 164:5 (2011), 957–965.
16. Feldman, S.R., Bushnell, D.M., Klekotka, P.A., Scanlon, M., Martin, M.L., Wade, S.W., Yang, W., Pinto, L., Kircik, L., Viswanathan, H.N., Differences in psoriasis signs and symptom severity between patients with clear and almost clear skin in clinical practice. J. Dermatolog. Treat. 27:3 (2016), 224–227.
17. Lee, Y., Je, Y.J., Lee, S.S., Li, Z.J., Choi, D.K., Kwon, Y.B., Sohn, K.C., Im, M., Seo, Y.J., Lee, J.H., Changes in transepidermal water loss and skin hydration according to expression of aquaporin-3 in psoriasis. Ann. Dermatol. 24:2 (2012), 168–174.
18. Kemeny, A., Kodji, X., Horvath, S., Komlodi, R., Szoke, E., Sandor, Z., Perkecz, A., Gyomorei, C., Setalo, G., Kelemen, B., Biro, T., Toth, B.I., Brain, S.D., Pinter, E., Gyulai, R., TRPA1 acts in a protective manner in imiquimod-induced psoriasiform dermatitis in mice. J. Invest. Dermatol. 138:8 (2018), 1774–1784.
19. Liu, M., Li, X., Chen, X.Y., Xue, F., Zheng, J., Topical application of a linoleic acid-ceramide containing moisturizer exhibit therapeutic and preventive benefits for psoriasis vulgaris: a randomized controlled trial. Dermatol. Ther. 28:6 (2015), 373–382.
20. Darlenski, R., Hristakieva, E., Aydin, U., Gancheva, D., Gancheva, T., Zheleva, A., Gadjeva, V., Fluhr, J.W., Epidermal barrier and oxidative stress parameters improve during in 311nm narrow band UVB phototherapy of plaque type psoriasis. J. Dermatol. Sci. 91:1 (2018), 28–34.
21. Yun, J.W., Seo, J.A., Jeong, Y.S., Bae, I.H., Jang, W.H., Lee, J., Kim, S.Y., Shin, S.S., Woo, B.Y., Lee, K.W., Lim, K.M., Park, Y.H., TRPV1 antagonist can suppress the atopic dermatitis-like symptoms by accelerating skin barrier recovery. J. Dermatol. Sci. 62:1 (2011), 8–15.
22. Kim, B.E., Howell, M.D., Guttman-Yassky, E., Gilleaudeau, P.M., Cardinale, I.R., Boguniewicz, M., Krueger, J.G., Leung, D.Y., TNF-alpha downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-alpha antagonists to improve skin barrier. J. Invest. Dermatol. 131:6 (2011), 1272–1279.
23. Bertin, S., Aoki-Nonaka, Y., de Jong, P.R., Nohara, L.L., Xu, H., Stanwood, S.R., Srikanth, S., Lee, J., To, K., Abramson, L., Yu, T., Han, T., Touma, R., Li, X., Gonzalez-Navajas, J.M., Herdman, S., Corr, M., Fu, G., Dong, H., Gwack, Y., Franco, A., Jefferies, W.A., Raz, E., The ion channel TRPV1 regulates the activation and proinflammatory properties of CD4(+) T cells. Nat. Immunol. 15:11 (2014), 1055–1063.
24. Mashiko, S., Bouguermouh, S., Rubio, M., Baba, N., Bissonnette, R., Sarfati, M., Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis. J. Allergy Clin. Immunol., 136(2), 2015 351-9 e1.
25. Jin, S.P., Koh, S.J., Yu, D.A., Kim, M.W., Yun, H.T., Lee, D.H., Yoon, H.S., Cho, S., Park, H.S., Imiquimod-applied Interleukin-10 deficient mice better reflects severe and persistent psoriasis with systemic inflammatory state. Exp. Dermatol. 27:1 (2018), 43–49.